190 related articles for article (PubMed ID: 7822118)
21. Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.
Doucet JP; Bazan NG
Mol Neurobiol; 1992; 6(4):407-24. PubMed ID: 1337456
[TBL] [Abstract][Full Text] [Related]
22. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors.
Aarts MM; Tymianski M
Biochem Pharmacol; 2003 Sep; 66(6):877-86. PubMed ID: 12963474
[TBL] [Abstract][Full Text] [Related]
23. The role of excitotoxicity in neurodegenerative disease: implications for therapy.
Doble A
Pharmacol Ther; 1999 Mar; 81(3):163-221. PubMed ID: 10334661
[TBL] [Abstract][Full Text] [Related]
24. Differential vulnerability to excitatory amino acid-induced toxicity and selective neuronal loss in neurodegenerative diseases.
Weiss JH; Choi DW
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):394-7. PubMed ID: 1657348
[TBL] [Abstract][Full Text] [Related]
25. Excitatory amino acid receptors and neurodegeneration.
Doble A
Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
[TBL] [Abstract][Full Text] [Related]
26. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy.
Bazan NG; Birkle DL; Tang W; Reddy TS
Adv Neurol; 1986; 44():879-902. PubMed ID: 3010683
[TBL] [Abstract][Full Text] [Related]
27. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion.
Das DK; Engelman RM; Rousou JA; Breyer RH; Otani H; Lemeshow S
Am J Physiol; 1986 Jul; 251(1 Pt 2):H71-9. PubMed ID: 2942042
[TBL] [Abstract][Full Text] [Related]
28. Involvement of phospholipase A2 in neurodegeneration.
Farooqui AA; Yang HC; Horrocks L
Neurochem Int; 1997 Jun; 30(6):517-22. PubMed ID: 9152992
[TBL] [Abstract][Full Text] [Related]
29. Excitatory transmitter neurotoxicity.
Olney JW
Neurobiol Aging; 1994; 15(2):259-60. PubMed ID: 7838306
[TBL] [Abstract][Full Text] [Related]
30. Manipulation of fatty acid composition of membrane phospholipid and its effects on cell growth in mouse LM cells.
Doi O; Doi F; Schroeder F; Alberts AW; Vagelos PR
Biochim Biophys Acta; 1978 May; 509(2):239-50. PubMed ID: 656411
[TBL] [Abstract][Full Text] [Related]
31. Phospholipids as the molecular instruments of ion and solute transport in biological membranes.
Green DE; Fry M; Blondin GA
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):257-61. PubMed ID: 6928617
[TBL] [Abstract][Full Text] [Related]
32. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
Chen WF; Sung CS; Jean YH; Su TM; Wang HC; Ho JT; Huang SY; Lin CS; Wen ZH
Neuroscience; 2010 Feb; 165(4):1217-32. PubMed ID: 19932886
[TBL] [Abstract][Full Text] [Related]
33. Neurodegenerative disorders: clues from glutamate and energy metabolism.
Ikonomidou C; Turski L
Crit Rev Neurobiol; 1996; 10(2):239-63. PubMed ID: 8971131
[TBL] [Abstract][Full Text] [Related]
34. Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants.
Montoliu C; Humet M; Canales JJ; Burda J; Planells-Cases R; Sánchez-Baeza F; Carbonell T; Pérez-Payá E; Messeguer A; Ferrer-Montiel A; Felipo V
J Pharmacol Exp Ther; 2002 Apr; 301(1):29-36. PubMed ID: 11907154
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.
Farooqui AA; Ong WY; Horrocks LA
Pharmacol Rev; 2006 Sep; 58(3):591-620. PubMed ID: 16968951
[TBL] [Abstract][Full Text] [Related]
36. Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications.
Olloquequi J; Cornejo-Córdova E; Verdaguer E; Soriano FX; Binvignat O; Auladell C; Camins A
J Psychopharmacol; 2018 Mar; 32(3):265-275. PubMed ID: 29444621
[TBL] [Abstract][Full Text] [Related]
37. [Glutamate receptors in the central nervous system].
Kolonko A
Postepy Hig Med Dosw; 1995; 49(6):719-31. PubMed ID: 8700807
[TBL] [Abstract][Full Text] [Related]
38. [Protection of excitotoxicity].
Kwak S
No To Shinkei; 1996 Dec; 48(12):1077-85. PubMed ID: 8990475
[No Abstract] [Full Text] [Related]
39. Glutamate receptors, neurotoxicity and neurodegeneration.
Lau A; Tymianski M
Pflugers Arch; 2010 Jul; 460(2):525-42. PubMed ID: 20229265
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase A2 hydrolysis of membrane phospholipids causes structural alteration of the nicotinic acetylcholine receptor.
Villar MT; Artigues A; Ferragut JA; Gonzalez-Ros JM
Biochim Biophys Acta; 1988 Feb; 938(1):35-43. PubMed ID: 3337815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
